The positive percentage of increased expression of G3BP1 and YB1 proteins was 57.5% (69/120) and 61.7% (74/120) in lung SCC, 55.1% (70/127) and 57.5% (73/127) in lung ADC, and 14.6% (7/48) and 12.5% (6/48) in noncancerous control lung tissues, respectively. This evidence concerns the gene YBX1 and medical procedure.